JELL.F Stock Overview
Engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
JEOL Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥35.06 |
| 52 Week High | JP¥35.11 |
| 52 Week Low | JP¥27.54 |
| Beta | 1.18 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 446.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| JELL.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | 1.0% |
| 1Y | n/a | 0.008% | 27.2% |
Return vs Industry: Insufficient data to determine how JELL.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how JELL.F performed against the US Market.
Price Volatility
| JELL.F volatility | |
|---|---|
| JELL.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: JELL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine JELL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 3,351 | Izumi Oi | www.jeol.co.jp |
JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide. The company operates through three segments: Scientific and Measuring Instruments Business, Industrial Equipment Business, and the Medical Equipment Business. It provides transmission electron microscopes; scanning electron microscopes; nuclear resonance and mass spectrometer; x-ray fluorescence spectrometer; electron diffractometer; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for microarea and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; electron beam lithography systems; electron microscope for semiconductors; and clinical chemistry analyzers.
JEOL Ltd. Fundamentals Summary
| JELL.F fundamental statistics | |
|---|---|
| Market cap | US$1.63b |
| Earnings (TTM) | US$109.29m |
| Revenue (TTM) | US$1.09b |
14.9x
P/E Ratio1.5x
P/S RatioIs JELL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JELL.F income statement (TTM) | |
|---|---|
| Revenue | JP¥162.50b |
| Cost of Revenue | JP¥89.20b |
| Gross Profit | JP¥73.31b |
| Other Expenses | JP¥56.97b |
| Earnings | JP¥16.34b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 10, 2023
| Earnings per share (EPS) | 319.89 |
| Gross Margin | 45.11% |
| Net Profit Margin | 10.05% |
| Debt/Equity Ratio | 9.8% |
How did JELL.F perform over the long term?
See historical performance and comparison